Centrient initiates patent litigation in India against Dalas Biotech
Centrient Pharma, in a lawsuit filed at Delhi HC, claims that Dalas Biotech has infringed upon its patent for the enzymatic…
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Category
Latest Updates
J&J hip implants: Drug regulator orders compensation for two more patients
Central Drugs Standard Control Organisation (CDSCO) has directed the compensation to be paid within 30 days from the date of…
Lupin in alliance with Natco receives USFDA approval for Bosentan tablets
The tablets are indicated for the treatment of pulmonary arterial hypertension in adults to improve exercise ability and to…
MTaI supports DTAB’s proposal for new vertical in CDSCO to check ‘garage…
The association states that creation of a separate vertical in Central Drugs Standard Control Organisation (CDSCO) exclusively to…
Merck- FSSAI collaboration starts a Center for Microbiological Analysis Training (C-MAT)
Merck and FSSAI have started a microbiological testing laboratory to enhance skill development in food safety industry
Research conducted at IIT Mandi shows that zinc supplementation suppresses fat deposition in the…
In a research study done by scientists at IIT Mandi, it was found that zinc oxide nanoparticles can prevent fat accumulation in…
Takeda announces Andrey Potapov as ICMEA Area Head
Potapov, who was previously assigned as General Manager of Takeda's operations in Russia and Head of the CIS Area, has taken over…
Glenmark launches novel, globally-researched anti-diabetes drug Remogliflozin in India
Remogliflozin is an innovative, patent-protected sodium glucose co-transporter-2 (SGLT2) inhibitor indicated in treatment of…
Cipla receives final approval for generic version of Gilead Sciences’ Letairis
Cipla’s Ambrisentan Tablet, 5 mg and 10 mg, is an AB-rated generic therapeutic equivalent version of Gilead Sciences' Letairis
Decks cleared for expansion of Aurobindo Pharma’s plant in AP
Ministry of Environment, Forests and Climate Change has given clearance to Aurobindo Pharma's drugs and intermediates…
Gilead experimental NASH drug fails another study
California-based Gilead's experimental drug, selonsertib, aimed at treating the fatty liver disease failed to pass yet another…
GSK’s HIV drug wins European panel thumbs-up
The drug company has received approval from the European Medicines Agency (EMA) for its two-drug treatment for HIV infections…
FDA approves expanded label for Regeneron/Sanofi’s cholesterol drug
The FDA’s decision will allow the drug, developed by Regeneron along with Sanofi SA, to be prescribed to reduce the overall risk…
Dr Reddy’s Lab, Cipla arm recall drugs in US market
While Dr Reddy's Laboratories initiated recall after their drugs were found to be exposed to above 50 per cent relative humidity…
Chinese drugs worth over Rs 1.5 Crores seized by CDSCO in Chennai
Over 2300 kg of drugs, manufactured in China and illegally imported by Kawarlal &Co, Madhavaram and Ningbo Hitech Biochemicals…
DuPont chosen to provide probiotics for international pediatric sepsis research
The firm will provide probiotic drugs to the The Hospital for Sick Children (SickKids) for a pediatric sepsis research based in…
8th Annual Global Pharma Regulatory Summit to be held in May
UBM India has announced that the three-day international summit will be held in Mumbai, starting from 29th May, 2019
Biocon reports 26 per cent hike in revenue for Q4FY19
Biocon recently released its consolidated financial results for the fourth quarter and the fiscal year, 2019; also witnessed a 31…
US “Special 301″ Report undermines efforts to lower medicine prices globally: Leena Menghaney
Leena Menghaney, Head-South Asia, Médecins Sans Frontières (MSF), discusses the release of United States Trade Representative…
USFDA makes ‘certain’ observations for Torrent Pharma’s Indrad plant
The drug firm's plant facility in Gujarat, Indrad, was inspected by the USFDA in April